Background: Peripheral neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio
(PLR), and lymphocyte-to-monocyte ratio (LMR) have been widely reported prognostic …

Background In the peripheral blood, the neutrophil–lymphocyte ratio (NLR) and platelet–
lymphocyte ratio (PLR) change in response to malignancy. These biomarkers are …

Cancer‐related inflammation may play an important role in disease progression and patient
outcome, and could be easily monitored through indirect parameters routinely evaluated at …

Neutrophil-to-lymphocyte ratio is a strong predictor for overall survival and disease free
survival in many cancers. Our study is the first investigation aiming to determine the …

Background Elevated peripheral blood neutrophil-to-lymphocyte ratio (NLR) is associated
with poor oncologic outcomes in patients with stage IV melanoma and other solid tumors …

Simple Summary Unlike the neutrophil/lymphocyte ratio (NLR), more complex complete
blood count (CBC)-based systemic immune-inflammation cancer biomarkers have recently …

Background: A number of studies have investigated the prognostic impact of the neutrophil-
to-lymphocyte ratio (NLR) in patients with melanoma but the results were controversial …

Introduction Recently, the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) has
been widely evaluated in many cancers. Here we assessed the prognostic value of …

Several studies have reported that a high neutrophil-to-lymphocyte ratio (NLR) is associated
with poor clinical outcomes in several cancers, but this ratio has not been thoroughly studied …

Objectives The neutrophil–lymphocyte ratio (NLR) is an inflammatory biomarker which is
useful in cancer prognostication. We aimed to investigate the differences in baseline NLR …